A new psychedelic drug formulation called AKO004 is now under development by Akome Biotech, a wholly owned subsidiary of Core One Labs, as a potential treatment for Parkinson’s disease. The company has filed a provisional patent application for AKO004 with the U.S. Patent and Trademark Office. The AKO004 formulation comprises N, N-dimethyltryptamine, known as DMT, …
An Oregon review panel established under the state’s voter-approved therapeutic psilocybin legalization initiative has released a report stating that the psychedelic holds significant medical value for a number of mental health conditions. After reviewing about 600 studies that looked into psilocybin, a subcommittee of the Oregon Psilocybin Advisory Board determined that the substance is shown …
Massachusetts lawmakers on Tuesday heard testimony about a bill to create a task force charged with studying the implications of legalizing psychedelics like psilocybin and ayahuasca. The legislature’s Joint Judiciary Committee met to discuss legislation from Rep. Mike Connolly (D). While members didn’t vote on the proposal, the sponsor was able to make the case …
Sidebar tackles the top stories you need to know from the legal world. Join reporters Bianca Bruno, Nicholas Iovino and Nina Pullano as they take you in and out of courtrooms in the U.S. and beyond and break down developments to help you understand how they affect your day-to-day life. In Tuesday’s episode, we dig …
Sidebar: Shrooms, sex and more sex (allegedly) – Courthouse News Service Read More »
Law360 (July 26, 2021, 8:30 PM EDT) — The Drug Enforcement Administration has a responsibility to allow the use of Schedule I substances such as psychedelics for specific, medicinal purposes, a group of patients told the Ninth Circuit on Friday. According to the patients’ reply brief, the Controlled Substances Act must give way to a …
DEA Should Allow Psychedelic Therapy, 9th Circ. Told – Law360 Read More »
AOC’s psychedelics amendment; Congressman bulldozes marijuana plants; Vote to federally protect state laws next week; MS medical cannabis negotiations Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Paid for by …
Biden drug czar worked for cannabis firm (Newsletter: July 26, 2021) – Marijuana Moment Read More »
Investors are opening their minds and wallets to the possibilities of psychedelic-assisted therapies. Three biopharmaceutical companies aiming to make psychedelic drugs to treat mental health disorders have gone public in recent months: Peter Thiel-backed Atai Life Sciences IPO’d in June and now has a market cap of $2.6 billion; MindMed went public in April and …
ARCATA, Calif. (KIEM-TV)- Wednesday night the Arcata City Council listened to testimonies that painted a positive picture of mushrooms and other psychedelic drugs. On Wednesday night the Arcata City Council discussed the decriminalization of mushrooms and other psychedelic drugs. The council decided to move forward to speaking to the public safety committee next week. (Richard …
There’s no two ways to slice it: America is facing an epidemic of drug overdose deaths, and the crisis is at its worst closer to home. According to Centers for Disease Control data released last week, the United States saw 93,000 overdose deaths in 2020, a 30 percent increase from the previous year. California saw …
State Won’t Lead on Safe Drug Consumption Sites – SF Weekly Read More »
President Joe Biden’s pick to head up federal drug policy worked for a major marijuana business last year, according to his financial disclosure reports. Rahul Gupta, the nominee for director of the White House Office of National Drug Control Policy (ONDCP), worked as a consultant to Holistic Industries, a multi-state cannabis operator, for nine months …
Our aim is to ease the suffering of millions through charitable contributions.
© ELONGATE 2021. All rights reserved